Research/Valuation, page-635

I'd bet on something after a P3 readout if I were a gambling man, however I'm not, so I wouldn't want to be on the sidelines if something came earlier. The only reason I say that is that Clarity is a bit of a jump for big pharma compared to what they have been previously buying up (in that it's copper based), which whilst being a very good thing in my view perhaps requires more data before a larger player can make such a large acquisition. There's also the option of doing it alone, which in my view is definitely an option if necessary, and I would personally back this management team. It would probably add a bit of time before we get to pop open the champagne and celebrate our profits, but I reckon regardless of what happens Clarity should make us all very happy.